Datwyler introduces its First Line manufacturing concept and marks the production start of the newly expanded facility in Pune
Latest expansion of Pune facility; first commercial samples available in September 2018
- Expansion of the facility incorporates upgrade to First Line standard – the industry’s most advanced manufacturing concept for high-quality elastomer components is designed to exclusively produce Omni Flex components
- Rahul Dev, Vice President Datwyler India, emphasizes strategic value of the Indian market to Datwyler and introduces to the next expansion plans to come
Datwyler, the Swiss-based leading industrial supplier of state-of-the-art solutions for drug packaging and
medical devices, announced that the first commercial samples of the newly expanded First Line production in Pune will be available in September. The expansion of Datwyler’s facility in Pune to accommodate First Line,the company’s own state-of-the-art manufacturing and production concept in the industry, is almost completed.First Line is designed to produce the advanced closure solution Omni Flex.
Rahul Dev, Vice President India said, “The Indian market is of strategic value to Datwyler. As one of the global manufacturing destinations, India’s pharmaceutical and biotech markets continue to grow rapidly. With the expansion, we are hoping to satisfy the growing demand for high-quality elastomer components in regional and global markets.” Datwyler provides a unique range of future-proof health care sealing solutions and services for primary and secondary packaging. This includes the most advanced elastomer formulations, proprietary coatings, sterilization options, and aluminium seals for high-efficiency production lines, which not only meet the demands of current pharma trends, but go beyond them. In India, Datwyler’s core business consists of container closures.
Latest expansion completed, first commercial samples available in September
The latest expansion of Datwyler’s production facility in Pune is almost completed: While the full integration of the First Line production standard and Omni Flex production line will be integrated by August 2018, first
commercial samples will be available in September. Once the new production line is operating to full capacity,the company’s production volume will exceed approx. 4 billion components per year, enabling Datwyler to provide locally manufactured state-of-the-art elastomer components to a growing market. With the expanded operation, Datwyler has set a new milestone for cleanroom production in India and the region. The company is currently supplying to the top ten pharmaceutical companies and global players in the region.
First Line standard for high-quality elastomer components
Datwyler’s First Line manufacturing concept for high-quality elastomer components is based on ultra-modern cleanroom technology, automated production cells, fully automated camera inspection, and a unique validated washing process. Datwyler’s facilities aligned with the First Line manufacturing standard are specially designed to operate under a zero-defect philosophy. The process flow, gowning protocols, personnel and material flow,and state-of-the-art technology and automation all result in the lowest endotoxin, bioburden, particulate, and defect levels available in the industry. This innovative approach to manufacturing exceeds the most stringent quality standards of the European and US regulatory authorities and is certified to ISO 15378.
Datwyler to further develop its position in India
Today, Rahul Dev and Datwyler’s global health care team have hosted an interactive Tech Day in Hyderabad.The global R&D team and technical experts have introduced Datwyler’s regional customers to the company’s manufacturing concept First Line and discuss future challenges in the markets. Rahul Dev has also used the occasion to give a brief overview of further expansion plans for Pune to support the company’s strategic plans for India. The new expansion will cover an additional 24,000 m2 next to the existing facility and is expected to be completed in 2021.
DATWYLER | HEALTH CARE
The Datwyler Group is an international supplier of state-of-the-art industrial components with leading positions in global and regional market segments. As technological leader, the Datwyler Group delivers added value to its customers in all markets served. In its Sealing Solutions division, Datwyler provides customised sealing solutions to manufacturers and companies which operate in the health care and automotive industry, as well as the market segments civil engineering and consumer goods. Within the health care unit, Datwyler develops, designs and manufactures solutions for injectable packaging and drug delivery systems to facilitate customers to create a safer medical environment of tomorrow. The company develops complex and unique coatings and rubber compounds enabling customers to fill syringes with medicine and thus gives numerous people across the globe access to new medications. The products and services of Datwyler are built on highquality material, innovative technologies, outstanding engineering and process know-how. With a global manufacturing footprint on three continents, sales in over 100 countries and more than 7,000 employees, the Datwyler Group generates an annual revenue of approx. €
1.200 million. Looking back onto more than 100 years of history, Datwyler is a reliable partner, now and in the future.
Datwyler Sealing Solutions:
Simone Ramser, Vice President Communications, email@example.com, +41 41 875 1410
Naina Siwach, Genesis Burson-Marsteller, firstname.lastname@example.org, +91 7045646426